Molecular medicine (Cambridge, Mass.) · 2026
METTL3/YTHDC1 axis-mediated m6A modification of Foxo1 mRNA promote endothelial autophagic apoptosis in diabetic atherosclerosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhao Yujia, Tang Longjia, Zhang Hongtian, Liu Xu, Zhang Haonan, Zhao Ying, Chen Legao, Chen Xiaoting, Wu Xiaohong
Аннотация
BACKGROUND AND AIMS: Endothelial dysfunction is critical in diabetic angiopathy. While our previous study established role of FOXO1 in mediating advanced glycation end products (AGEs)-induced autophagic apoptosis in human aortic endothelial cells (HAECs), the potential mechanism of N6-methyladenosine (m6A) modification in this process remains unknown.
METHODS: RNA-m6A methylation and methyltransferase-like 3 (METTL3) / YTH domain containing 1 (YTHDC1) expression in carotid plaques of diabetic patients and aortic plaques of diabetic apoe-/- mice induced by STZ were detected by quantitative kit, immunohistochemical staining and immunofluorescence co-localization respectively. METTL3 and YTHDC1 were knocked down to observe changes in the m6A methylation status and expression of FOXO1. FOXO1 was overexpressed in METTL3-deficient HAECs to assess autophagic flux and apoptosis. Finally, the effect of METTL3 on atherosclerotic plaque formation was validated using endothelial cell-specific METTL3 knockout diabetic mice.
RESULTS: RNA m6A modification levels and the expression of the METTL3/YTHDC1 were upregulated in human diabetic carotid plaques, mouse aortic plaques, and AGEs-treated HAECs, accompanied by increased m6A methylation of Foxo1 mRNA. METTL3 mediates the AGEs-induced increase in m6A modification of Foxo1 mRNA, which is subsequently recognized by the YTHDC1 at a specific site in the 3'-UTR-3. This mechanism synergistically enhances FOXO1 expression and blocks autophagic flux leading to apoptosis in endothelial cells. In vivo, endothelial-specific METTL3 knockout attenuated aortic plaque formation in diabetic atherosclerotic mice and reduced FOXO1 expression along with autophagic apoptosis related proteins.
CONCLUSIONS: The METTL3/YTHDC1 axis-mediated m6A modification of Foxo1 mRNA promotes endothelial autophagic apoptosis in diabetic atherosclerosis, revealing a promising therapeutic target.
METHODS: RNA-m6A methylation and methyltransferase-like 3 (METTL3) / YTH domain containing 1 (YTHDC1) expression in carotid plaques of diabetic patients and aortic plaques of diabetic apoe-/- mice induced by STZ were detected by quantitative kit, immunohistochemical staining and immunofluorescence co-localization respectively. METTL3 and YTHDC1 were knocked down to observe changes in the m6A methylation status and expression of FOXO1. FOXO1 was overexpressed in METTL3-deficient HAECs to assess autophagic flux and apoptosis. Finally, the effect of METTL3 on atherosclerotic plaque formation was validated using endothelial cell-specific METTL3 knockout diabetic mice.
RESULTS: RNA m6A modification levels and the expression of the METTL3/YTHDC1 were upregulated in human diabetic carotid plaques, mouse aortic plaques, and AGEs-treated HAECs, accompanied by increased m6A methylation of Foxo1 mRNA. METTL3 mediates the AGEs-induced increase in m6A modification of Foxo1 mRNA, which is subsequently recognized by the YTHDC1 at a specific site in the 3'-UTR-3. This mechanism synergistically enhances FOXO1 expression and blocks autophagic flux leading to apoptosis in endothelial cells. In vivo, endothelial-specific METTL3 knockout attenuated aortic plaque formation in diabetic atherosclerotic mice and reduced FOXO1 expression along with autophagic apoptosis related proteins.
CONCLUSIONS: The METTL3/YTHDC1 axis-mediated m6A modification of Foxo1 mRNA promotes endothelial autophagic apoptosis in diabetic atherosclerosis, revealing a promising therapeutic target.